New drug linvoseltamab takes on multiple myeloma in early trial
NCT ID NCT05828511
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called linvoseltamab in people newly diagnosed with multiple myeloma, a type of blood cancer. The drug is designed to help the immune system attack cancer cells. The trial will check for side effects and see if the drug can shrink tumors. About 149 participants will take part, some before and after a stem cell transplant.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- linvoseltamab (a bispecific antibody that targets BCMA on myeloma cells and CD3 on immune cells)
- What this could lead to
- If successful, this could provide a new treatment option for newly diagnosed multiple myeloma, potentially improving response rates and depth of remission.
- What could go wrong
- This is an early-phase trial (Phase 1/2) with a small number of participants, so safety and effectiveness are not yet proven. Side effects, including immune reactions, are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU De Lille
NOT_YET_RECRUITINGLille, 59000, France
-
Centre Hospitalier Universitaire (CHU) Montpellier
RECRUITINGMontpellier, 342950, France
-
Centre Hospitalier Universitaire (CHU) de Poitiers
RECRUITINGPoitiers, Vienne, 86021, France
-
Clinica Universidad de Navarra
RECRUITINGPamplona, Navarre, 31008, Spain
-
Clinica Universidad de Navarra - Madrid
RECRUITINGMadrid, 28027, Spain
-
Colorado Blood Cancer Institute/SCRI
RECRUITINGDenver, Colorado, 80218, United States
-
Columbia University _ New York Presbyterian
RECRUITINGNew York, New York, 10032, United States
-
Duke University Health System (DUHS)
RECRUITINGDurham, North Carolina, 27705, United States
-
Gustave Roussy
RECRUITINGVillejuif, Île-de-France Region, 94800, France
-
Hopital Necker
RECRUITINGParis, Île-de-France Region, 75015, France
-
Hopital Prive d'Antony
RECRUITINGAntony, Île-de-France Region, 92160, France
-
Hopital Saint Louis
RECRUITINGParis, 75010, France
-
Hospital Clinic de Barcelona
RECRUITINGBarcelona, 08036, Spain
-
Hospital General Universitario Doctor Balmis Alicante
RECRUITINGAlicante, Valencia, 03010, Spain
-
Hospital Germans Trias i Pujol
RECRUITINGBadalona, Barcelona, 08916, Spain
-
Hospital Universitari i Politecnic La Fe
RECRUITINGValencia, 46026, Spain
-
Hospital Universitario Central de Asturias
RECRUITINGOviedo, Principality of Asturias, 33011, Spain
-
Hospital Universitario Quiron Salud Madrid
RECRUITINGPozuelo de Alarcón, Madrid, 28223, Spain
-
Hospital Universitario de Salamanca
RECRUITINGSalamanca, 37007, Spain
-
Institut Catala dOncologia (ICO Hospitalet)
RECRUITINGBarcelona, 08908, Spain
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
-
Levine Cancer Institute
RECRUITINGCharlotte, North Carolina, 28204, United States
-
Norton Cancer Institute
RECRUITINGLouisville, Kentucky, 40207, United States
-
Perlmutter Cancer Center
RECRUITINGNew York, New York, 10016, United States
-
Perlmutter Cancer Center at NYU Langone Hospital - Long Island
RECRUITINGMineola, New York, 11501, United States
-
Rutgers Cancer Institute of New Jersey
RECRUITINGNew Brunswick, New Jersey, 08901, United States
-
Stony Brook University Hospital
RECRUITINGStony Brook, New York, 11794, United States
-
The University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
UC Irvine Health
RECRUITINGOrange, California, 92868, United States
-
Universitary Hospital La Princesa
RECRUITINGMadrid, 28006, Spain
-
University Hospitals Pitie Salpetriere - Charles Foix
RECRUITINGParis, 75651, France
-
University of California Los Angeles (UCLA)
RECRUITINGLos Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact